• The New Money
  • Posts
  • $100 Million For MDMA, The UK's Uranium Bet, and CleanSpark Prepares For Bitcoin Mania

$100 Million For MDMA, The UK's Uranium Bet, and CleanSpark Prepares For Bitcoin Mania

Uncovering the world’s most exciting early stage companies. Discover what’s next.

Lykos Therapeutics Launches With $100 Million For MDMA Treatments

The Multidisciplinary Association for Psychedelic Studies, most commonly referred to as MAPS, has officially launched Lykos Therapeutics as a for profit biotechnology company to advance MDMA assisted therapies. The company has raised $100 million in a Series A financing led by Helena and with participation from hedge fund billionaire Steve Cohen.

The United Kingdom is Betting Big on Uranium Production

The United Kingdom has announced a historic move to commit €300 million into high assay low enriched uranium (HALEU) production, making the UK the first country in Europe to launch a high tech initiative in the space. With Russia currently being the main commercial producer for Europe, the United Kingdom’s move aims to increase energy independence and take advantage of the growing global demand for uranium.

CleanSpark Inks Massive BTC Miner Order To Prepare For Bitcoin Mania

CleanSpark (NASDAQ:CLSK) announced a new purchase agreement with Bitmain for 160,000 S21 Bitcoin miners. 60,000 of the miners will be delivered to CleanSpark in the coming months at a purchase price of $193.2 million, with the company maintaining a call option to buy another 100,000 miners in the future.

The Sprint

New here? Join our community of 16,000+ individuals interested in uncovering the world’s most exciting early stage companies.